Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Primary Central Nervous System Lymphoma (PCNSL)
100%
Hospital Setting
100%
Real-world Comparison
100%
Safety-net Hospital
80%
Public Safety Net
60%
Treatment Patterns
40%
Overall Survival
40%
Clinical Trials
20%
AIDS/HIV
20%
Hispanic
20%
Collaborative Care
20%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
20%
Treatment Outcome
20%
Consolidation Therapy
20%
Poor Outcome
20%
Induction Chemotherapy
20%
Resource-limited Settings
20%
Whole Brain Radiation Therapy
20%
Personalized Therapy
20%
Young Age
20%
High Prevalence
20%
Age-adjusted
20%
Progression-free
20%
Lymphoma Patients
20%
Academic Center
20%
Adjusted Analysis
20%
Survival Disparities
20%
Hospital Location
20%
Lymphoma Therapy
20%
Access Disparities
20%
Equitable Access
20%
Academic Cancer Center
20%
Care Delivery
20%
Safety-net Populations
20%
Medicine and Dentistry
Overall Survival
100%
Primary Central Nervous System Lymphoma
100%
Malignant Neoplasm
50%
Clinical Trial
50%
HIV/AIDS
50%
Personalized Medicine
50%
Prevalence
50%
Autologous Stem Cell Transplantation
50%
Progression Free Survival
50%
Whole Brain Radiotherapy
50%
Induction Chemotherapy
50%
Nursing and Health Professions
Hospital Setting
100%
Safety Net Hospital
100%
Primary Central Nervous System Lymphoma
100%
Overall Survival
50%
Cancer Center
25%
Induction Chemotherapy
25%
Human Immunodeficiency Virus
25%
Prevalence
25%
Progression Free Survival
25%
Whole Brain Radiotherapy
25%
Personalized Medicine
25%
Autologous Stem Cell Transplantation
25%